Invention Grant
- Patent Title: Prolyl hydroxylase inhibitors and methods of use
-
Application No.: US16119146Application Date: 2018-08-31
-
Publication No.: US10729681B2Publication Date: 2020-08-04
- Inventor: Richard Masaru Kawamoto , Shengde Wu , Artem G. Evdokimov , Kenneth D. Greis , Angelique Sun Boyer , Namal C. Warshakoon
- Applicant: Akebia Therapeutics, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Akebia Therapeutics, Inc.
- Current Assignee: Akebia Therapeutics, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Proskauer Rose LLP
- Agent Fangli Chen
- Main IPC: A61K31/4418
- IPC: A61K31/4418 ; C07C235/60 ; C07C237/42 ; C07C255/57 ; C07D213/81 ; C07D213/65 ; C07D405/10 ; C07D405/04 ; C07D295/192 ; C07D401/04 ; C07D401/10 ; C07D417/04 ; A61K31/4433
Abstract:
The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.
Public/Granted literature
- US20190192494A1 PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE Public/Granted day:2019-06-27
Information query
IPC分类:
